Medically reviewed by Fedorchenko Olga Valeryevna, PharmD. Last updated on 2020-03-26
Attention! Information on this page is intended only for medical professionals! Information is collected in open sources and may contain significant errors! Be careful and double-check all the information on this page!
Inside regardless of food intake, adults and children over 12 years — 1-2 tablets 3-4 times a day, children 6-12 years — 1 table 2-3 times a day, children 3-6 years-1/2-1 table 2-3 times a day.
The therapeutic effect of the drug is most pronounced when it is prescribed in the initial period of the disease. The duration of treatment depends on the form and severity of the disease.
In the case of common rashes with acute and recurrent forms of herpes simplex, both genital and extragenital localization, as well as in the presence of fever, lymphadenopathy and other common phenomena, the drug is used for 5-14 days, with Kaposi's herpetiform eczema and CMV infection-for 7-21 days as part of complex therapy, with aphthous stomatitis, the drug is prescribed for 5-15 days, with diseases caused by Herpes zoster (shingles) and Varicella zoster (chickenpox) — within 5-21 days.
In case of relapses, repeated courses of treatment with the drug are carried out. To prevent relapses of herpesvirus infections, the drug is prescribed a month after the end of treatment for 10-14 days.
The maximum daily dose of the drug for children over 12 years of age and adults is 800 mg (8 tables), for children 3-12 years of age — 300 mg (3 tables).
- Antiviral agent [Antiviral drugs (excluding HIV) ]
In a place protected from light, at a temperature not exceeding 25 °C.
Keep out of reach of children.Shelf life of the drug Alpizarin®5 лет.
Do not use after the expiration date indicated on the package.
|tetrahydroxyglucopyranosylxanthene (Alpizarin®) (based on 100% substance)||0.1 g|
|excipients: milk sugar (lactose) - 0.1 g, potato starch-0.0475 g, calcium stearate (calcium stearic acid) - 0.0025 g|
Tablets of 100 mg. On 10, 20, 30 tables. in a contour cell packaging made of PVC film and aluminum foil printed with a thermolac coating.
2 contour cell packages No. 10 or 1 contour cell package No. 20 or No. 30 are placed in a pack of cardboard for consumer packaging.
J05AX Other antiviral drugs
- A60. 9 Anogenital herpetic infection, unspecified
- B00. 0 Herpetic eczema
- B00. 2 Herpetic gingivostomatitis and pharyngotonsillitis
- B00. 9 Herpetic infection, unspecified
- B01 Chickenpox [varicella]
- B02 Shingles [herpes zoster]
- B25. 9 Cytomegalovirus disease, unspecified
- K12. 0 Recurrent oral aphthae